Volume 3, Issue 2 (June, 2024) – 6 articles
Cover Picture: There is a dearth of information on in vitro oral bioaccessibility, challenging the evaluation of the health risks arising from indoor dust exposure to the brominated flame retardants, tetrabromobisphenol A (TBBPA), and hexabromocyclododecane (HBCDD). Here, we estimate the human oral bioaccessibility of TBBPA and HBCDD in indoor dust by applying the standardized bioaccessibility test under fasting (UBM-like test) and fed (FOREhST test) conditions.
